We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-8.86%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$220M
AUM Growth
-$17M
Cap. Flow
-$6.31M
Cap. Flow %
-2.87%
Top 10 Hldgs %
36.95%
Holding
108
New
33
Increased
19
Reduced
16
Closed
31

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$8.56M
2
ABT icon
Abbott
ABT
+$4.95M
3
AET
Aetna Inc
AET
+$4.28M
4
ATHN
Athenahealth, Inc.
ATHN
+$4.12M
5
SHPG
Shire pic
SHPG
+$3.89M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$8.41M
2
BRKR icon
Bruker
BRKR
+$6.43M
3
TFX icon
Teleflex
TFX
+$5.58M
4
LIVN icon
LivaNova
LIVN
+$4.01M
5
NUVA
NuVasive, Inc.
NUVA
+$3.63M

Sector Composition

Rank Sector Weight
1 Healthcare 59.86%
2 Financials 2.04%
3 Industrials 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVHC
26
DELISTED
Envision Healthcare Holdings Inc
EVHC
$3.57M 1.62%
58,450
+31,730
+119% +$2.08M
WMGI
27
DELISTED
Wright Medical Group Inc
WMGI
$3.52M 1.6%
211,922
+25,922
+14% +$481K
LLY icon
28
Eli Lilly
LLY
$1.09T
$3.02M 1.38%
42,000
+7,500
+22% +$567K
IVC
29
DELISTED
Invacare Corporation
IVC
$2.96M 1.35%
+225,000
New +$3.19M
MCK icon
30
McKesson
MCK
$105B
$2.91M 1.32%
+18,500
New +$2.99M
ACAD icon
31
CALL
Acadia Pharmaceuticals
ACAD
$5.06B
$2.8M 1.27%
+100,000
New +$2.18M
ARAY icon
32
Accuray
ARAY
$36.1M
$2.55M 1.16%
441,300
+11,300
+3% +$62.6K
CYNA
33
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
$2.36M 1.07%
194,461
– –
TFX icon
34
Teleflex
TFX
$5.91B
$2.35M 1.07%
15,000
-40,000
-73% -$5.58M
TFX icon
35
PUT
Teleflex
TFX
$5.91B
$2.35M 1.07%
+15,000
New +$2.09M
ALGN icon
36
PUT
Align Technology
ALGN
$12.3B
$2.18M 0.99%
30,000
-25,000
-45% -$1.64M
ATRC icon
37
AtriCure
ATRC
$2.18B
$2.08M 0.94%
123,450
+75,000
+155% +$1.32M
SPY icon
38
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$2.06M 0.93%
10,000
-20,000
-67% -$3.9M
VTRS icon
39
Viatris
VTRS
$18.7B
$2.04M 0.93%
+44,000
New +$2.12M
XLV icon
40
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$44B
$2.03M 0.92%
30,000
-45,000
-60% -$3.01M
SIEN
41
DELISTED
Sientra, Inc.
SIEN
$1.98M 0.9%
28,948
-1,982
-6% -$149K
BIIB icon
42
Biogen
BIIB
$30.4B
$1.95M 0.89%
+7,500
New +$1.98M
SRPT icon
43
PUT
Sarepta Therapeutics
SRPT
$1.87B
$1.95M 0.89%
+100,000
New +$1.75M
CELG
44
DELISTED
Celgene Corp
CELG
$1.91M 0.87%
+19,125
New +$1.97M
CNC icon
45
Centene
CNC
$32.4B
$1.88M 0.85%
+61,048
New +$1.82M
MDVN
46
DELISTED
MEDIVATION, INC.
MDVN
$1.71M 0.78%
+37,250
New +$1.35M
KITE
47
DELISTED
Kite Pharma, Inc.
KITE
$1.71M 0.78%
37,250
-4,200
-10% -$203K
AMRN
48
Amarin Corp
AMRN
$298M
$1.66M 0.76%
+54,375
New +$1.61M
IVC
49
CALL
DELISTED
Invacare Corporation
IVC
$1.65M 0.75%
+125,000
New +$1.77M
SGYP
50
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$1.58M 0.72%
572,800
+200,000
+54% +$724K
1
2
3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2016 Portfolio in Review

As of Q1 2016, Pura Vida Investments held 108 positions worth $220M, down 7.2% from $237M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Pura Vida Investments's Q1 2016 filing shows 33 new, 19 increased, 16 reduced and 31 closed positions. Its largest new stake was Abbott: 125,000 shares worth $5.23M. The largest sale was Cigna, an estimated $8.41M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 56% a quarter earlier, followed by Financials and Industrials.

  • Pura Vida Investments's largest Q1 2016 buy was Abbott: 125,000 shares worth $5.23M.
  • Pura Vida Investments added most to Allergan plc in Q1 2016, an estimated $8.56M increase.
  • Pura Vida Investments's biggest Q1 2016 reduction was Teleflex, cutting an estimated $5.58M.
  • Pura Vida Investments fully exited Cigna in Q1 2016, selling an estimated $8.41M.
  • Pura Vida Investments's ten largest holdings make up 37% of its $220M portfolio in Q1 2016.
  • Pura Vida Investments opened 33 new positions and closed 31 in Q1 2016.
  • Pura Vida Investments's portfolio value fell 7.2% quarter-over-quarter to $220M.

Based on Pura Vida Investments's 13F filing for Q1 2016, filed 16 May 2016.